David S. Lawrence

4.0k total citations
100 papers, 2.1k citations indexed

About

David S. Lawrence is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, David S. Lawrence has authored 100 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 34 papers in Infectious Diseases and 27 papers in Molecular Biology. Recurrent topics in David S. Lawrence's work include Fungal Infections and Studies (24 papers), Antifungal resistance and susceptibility (19 papers) and Chemical Synthesis and Analysis (12 papers). David S. Lawrence is often cited by papers focused on Fungal Infections and Studies (24 papers), Antifungal resistance and susceptibility (19 papers) and Chemical Synthesis and Analysis (12 papers). David S. Lawrence collaborates with scholars based in United Kingdom, United States and Botswana. David S. Lawrence's co-authors include Charles D. Smith, Jean E. Copper, Charles D. Smith, Joseph N Jarvis, Jack T. Zilfou, Qunzhao Wang, Mel Krajden, Annie Mak, Martin Petric and Tae Ryong Lee and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

David S. Lawrence

92 papers receiving 2.0k citations

Peers

David S. Lawrence

EPIDE

PHYSI

Jing Tang China

Yanru Feng China

Elizaveta Padalko Belgium

Binod Kumar United States

Han G. Huisman Netherlands

Jocelyne Piret Canada

William M. Mitchell United States

Kazuo Tamura Japan

Fang Yu United States

Jesse J. Kwiek United States

Jing Tang China

David S. Lawrence

624 ×0.8

EPIDE

715 ×1.3

565 ×1.3

231 ×0.8

92 ×0.5

PHYSI

Citations per year, relative to David S. Lawrence David S. Lawrence (= 1×) peers Jing Tang

Countries citing papers authored by David S. Lawrence

Since Specialization

Citations

This map shows the geographic impact of David S. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Lawrence more than expected).

Fields of papers citing papers by David S. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Lawrence. The network helps show where David S. Lawrence may publish in the future.

Co-authorship network of co-authors of David S. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Lawrence. A scholar is included among the top collaborators of David S. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Lawrence. David S. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueno, Akitoshi, Ross Murtagh, Seyed Alireza Mortazavi, et al.. (2025). Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta‐analysis. HIV Medicine. 27(1). 120–135.

Jarvis, Joseph N, Peter Ehrenkranz, David S. Lawrence, et al.. (2025). Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS. The Lancet HIV. 13(3). e207–e212.

Ford, Nathan, Ajay Rangaraj, Joseph N Jarvis, et al.. (2025). Interventions to Support People With HIV Following Hospital Discharge: A Systematic Review. Open Forum Infectious Diseases. 12(4). ofaf175–ofaf175.

Laker, Eva, et al.. (2025). Ethical issues surrounding the implementation of long-acting injectable antiretroviral therapy in sub-Saharan Africa. International Health. 17(5). 695–700. 1 indexed citations

Stott, Katharine E., Jennifer L. Tenor, Dena L. Toffaletti, et al.. (2024). Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis. mBio. 15(10). e0159224–e0159224. 1 indexed citations

Lawrence, David S., Agnes Ssali, Thomas S. Harrison, et al.. (2022). The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda. PLoS neglected tropical diseases. 16(10). e0010825–e0010825. 6 indexed citations

Moyo, Sikhulile, Kwana Lechiile, Tshepo Leeme, et al.. (2022). Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana. Biomedicines. 10(6). 1399–1399. 3 indexed citations

Lawrence, David S., Agnes Ssali, Zivai Mupambireyi, et al.. (2021). The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis. BMJ Open. 11(4). e039191–e039191. 8 indexed citations

Lawrence, David S., et al.. (2020). Decolonising global health: transnational research partnerships under the spotlight. International Health. 12(6). 518–523. 65 indexed citations

10.

Moyo, Sikhulile, Kwana Lechiile, Tshepo Leeme, et al.. (2020). HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana. Viruses. 12(12). 1404–1404. 2 indexed citations

11.

Moyo, Sikhulile, Kwana Lechiile, Dorcas Maruapula, et al.. (2020). Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana. Medicine. 99(41). e22606–e22606. 4 indexed citations

12.

O’Banion, Colin P., Melanie A. Priestman, Robert M. Hughes, et al.. (2017). Design and Profiling of a Subcellular Targeted Optogenetic cAMP-Dependent Protein Kinase. Cell chemical biology. 25(1). 100–109.e8. 30 indexed citations

13.

Lawrence, David S., et al.. (2014). Young people's opinions about herbal medicines in a suburban district of Central Uganda. International Health. 6(4). 337–338. 4 indexed citations

14.

Sharma, Vyas & David S. Lawrence. (2009). Über‐Responsive Peptide‐Based Sensors of Signaling Proteins. Angewandte Chemie International Edition. 48(40). 7290–7292. 15 indexed citations

15.

Morrison, Christopher D., Christy L. White, Zhong Wang, et al.. (2006). Increased Hypothalamic Protein Tyrosine Phosphatase 1B Contributes to Leptin Resistance with Age. Endocrinology. 148(1). 433–440. 90 indexed citations

16.

Liang, Fubo, Zhonghui Huang, Jiao Liang, et al.. (2003). Aurintricarboxylic Acid Blocks in Vitro and in Vivo Activity of YopH, an Essential Virulent Factor of Yersinia pestis, the Agent of Plague. Journal of Biological Chemistry. 278(43). 41734–41741. 71 indexed citations

17.

Smith, Christopher, Christina Myers, Jack T. Zilfou, S.N. Smith, & David S. Lawrence. (2001). Indoloquinoxaline Compounds That Selectively Antagonize P-Glycoprotein. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 12(5). 219–229. 14 indexed citations

18.

Lawrence, David S., Jean E. Copper, & Charles D. Smith. (2000). Structure−Activity Studies of Substituted Quinoxalinones as Multiple-Drug-Resistance Antagonists. Journal of Medicinal Chemistry. 44(4). 594–601. 153 indexed citations

19.

Corbin, Jackie D., et al.. (1996). Precision Targeting of Protein Kinases. Journal of Biological Chemistry. 271(4). 1845–1848. 15 indexed citations

20.

Kendall, M. J., et al.. (1973). Haematology and Biochemistry of Ankylosing Spondylitis. BMJ. 2(5860). 235–237. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact